10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

Rhea-AI Summary

10x Genomics (Nasdaq: TXG), a leader in single cell and spatial biology, has scheduled its Q2 2025 earnings release for August 7, 2025, after market close. The company will host a conference call and webcast at 1:30 PM PT / 4:30 PM ET to discuss financial results and business developments.

The earnings release will be available on the company's website before the call, and investors can access the live webcast through the investor relations section. A replay will be available for at least 45 days following the event.

News Market Reaction – TXG

+1.43%

+1.43% Session move

In the trading session that priced this news, TXG gained 1.43%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLEASANTON, Calif., July 10, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the second quarter ended June 30, 2025 after market close on Thursday, August 7, 2025. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Live audio of the webcast will be available on the "Investors" section of the company website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

Contacts

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-second-quarter-2025-financial-results-on-august-7-2025-302502761.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics (TXG) report Q2 2025 earnings?

10x Genomics will report Q2 2025 earnings on Thursday, August 7, 2025 after market close.

What time is the 10x Genomics Q2 2025 earnings call?

The earnings call will begin at 1:30 PM Pacific Time / 4:30 PM Eastern Time on August 7, 2025.

How can I access the 10x Genomics Q2 2025 earnings call?

The live webcast will be available on the Investors section of the company website at investors.10xgenomics.com.

How long will the 10x Genomics Q2 2025 earnings call replay be available?

The webcast replay will be archived and available for at least 45 days after the event.